BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries | Zendy

Tanja Zeller | Zendy; Maria Hughes | Zendy; Tarja Tuovinen | Zendy; Arne Schillert | Zendy; Annette ConradsFrank | Zendy; Hester M. den Ruijter | Zendy; Renate B. Schnabel | Zendy; Frank Kee | Zendy; Veikko Salomaa | Zendy; Uwe Siebert | Zendy; Barbara Thorand | Zendy; Andreas Ziegler | Zendy; Heico Breek | Zendy; Gerard Pasterkamp | Zendy; Kari Kuulasmaa | Zendy; Wolfgang Köenig | Zendy; Stefan Blankenberg | Zendy

Open Access

BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries

Author(s) -

Tanja Zeller,

Maria Hughes,

Tarja Tuovinen,

Arne Schillert,

Annette ConradsFrank,

Hester M. den Ruijter,

Renate B. Schnabel,

Frank Kee,

Veikko Salomaa,

Uwe Siebert,

Barbara Thorand,

Andreas Ziegler,

Heico Breek,

Gerard Pasterkamp,

Kari Kuulasmaa,

Wolfgang Köenig,

Stefan Blankenberg

Publication year - 2014

Publication title -

european journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.825

H-Index - 111

eISSN - 1573-7284

pISSN - 0393-2990

DOI - 10.1007/s10654-014-9952-x

Subject(s) - medicine , biomarker , epidemiology , risk assessment , estimation , biomarker discovery , environmental health , disease , biochemistry , chemistry , computer security , management , computer science , economics , proteomics , gene

Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role towards personalised medicine remains uncertain. Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) is an European collaborative research project with the primary objective to assess the value of established and emerging biomarkers for cardiovascular risk prediction. BiomarCaRE integrates clinical and epidemiological biomarker research and commercial enterprises throughout Europe to combine innovation in biomarker discovery for cardiovascular disease prediction with consecutive validation of biomarker effectiveness in large, well-defined primary and secondary prevention cohorts including over 300,000 participants from 13 European countries. Results from this study will contribute to improved cardiovascular risk prediction across different European populations. The present publication describes the rationale and design of the BiomarCaRE project.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research